Timothy Brooks to Case-Control Studies
This is a "connection" page, showing publications Timothy Brooks has written about Case-Control Studies.
Connection Strength
0.029
-
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet. 2021 03 20; 397(10279):1057-1058.
Score: 0.014
-
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection. Sci Immunol. 2020 12 23; 5(54).
Score: 0.014